22.69
0.73 (3.34%)
| Penutupan Terdahulu | 21.96 |
| Jumlah Dagangan | 241,888 |
| Harga / Pendapatan (P/E Ke hadapan) | 11.55 |
| Harga / Jualan (P/S) | 0.720 |
| Harga / Buku (P/B) | 3.71 |
| Julat 52 Minggu |
| Margin Keuntungan | -29.43% |
| Margin Operasi (TTM) | -3.81% |
| EPS Cair (TTM) | -8.39 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -1.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 149.92% |
| Nisbah Semasa (MRQ) | 0.970 |
| Aliran Tunai Operasi (OCF TTM) | 164.20 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 310.66 M |
| Pulangan Atas Aset (ROA TTM) | -1.74% |
| Pulangan Atas Ekuiti (ROE TTM) | -61.58% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Fortrea Holdings Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Nilai 35% | -2.1 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | -2.1 |
| Masa 35% | -0.3 |
| AI Technical info | NA |
| Osilator Teknikal info | -0.5 |
| Purata Bergerak Teknikal info | 0.0 |
| Wang Pintar 30% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | NA |
| Persekitaran | ×1.21 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -21.3% |
| Persetujuan Tonggak | ×1.25 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | -5.0 |
| Skor Akhir | -1.27 |
|
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 0.40% |
| % Dimiliki oleh Institusi | 101.90% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Corvex Management Lp | 30 Jun 2026 | 2,988,551 |
| Loomis Sayles & Co L P | 30 Jun 2026 | 2,440,583 |
| Park West Asset Management Llc | 30 Jun 2026 | 2,106,131 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |